We are live on ! Find out more
IAM

Iridian Asset Management Portfolio holdings

AUM $291M
1-Year Est. Return 49.45%
This Fund
S&P 500
This Quarter Est. Return
+3.59%
1 Year Est. Return
+49.45%
3 Year Est. Return
+82.55%
5 Year Est. Return
+101.12%
10 Year Est. Return
+450.66%
AUM
$467M
AUM Growth
+$24M
Cap. Flow
+$13.5M
Cap. Flow %
2.89%
Top 10 Hldgs %
56.69%
Holding
55
New
4
Increased
25
Reduced
17
Closed
2

Top Buys

Rank Stock Value
1
LPLA icon
LPL Financial
LPLA
+$8.16M
2
HLF icon
Herbalife
HLF
+$6.24M
3
WOLF icon
Wolfspeed
WOLF
+$5.85M
4
RTO icon
Rentokil
RTO
+$5.24M
5
BILL icon
BILL Holdings
BILL
+$3.22M

Top Sells

Rank Stock Value
1
CCK icon
Crown Holdings
CCK
+$6.77M
2
POST icon
Post Holdings
POST
+$4.66M
3
AVTR icon
Avantor
AVTR
+$3.44M
4
ICE icon
Intercontinental Exchange
ICE
+$3.32M
5
YOU icon
Clear Secure
YOU
+$2.83M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.76%
2 Miscellaneous 21.99%
3 Technology 16.12%
4 Healthcare 12.14%
5 Consumer Staples 8.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BTC
51
Grayscale Bitcoin Mini Trust ETF
BTC
$4.09B
$114K 0.02%
+4,060
New +$108K
AMPS
52
DELISTED
Altus Power
AMPS
$40.2K 0.01%
+12,653
New +$45.1K
DNMR
53
DELISTED
Danimer Scientific, Inc.
DNMR
$5.34K ﹤0.01%
294
AVTR icon
54
Avantor
AVTR
$10B
-162,133
Closed -$3.44M
DNA icon
55
Ginkgo Bioworks
DNA
$455M
-581
Closed -$7.77K

Similar funds

Iridian Asset Management's Q3 2024 Portfolio in Review

As of Q3 2024, Iridian Asset Management held 55 positions worth $467M, up 5.4% from $443M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Iridian Asset Management's Q3 2024 filing shows 4 new, 25 increased, 17 reduced and 2 closed positions. Its largest new stake was Nuvectis Pharma: 55,380 shares worth $348K. The largest sale was Crown Holdings, an estimated $6.77M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, down from 24% a quarter earlier, followed by Miscellaneous and Technology.

  • Iridian Asset Management's largest Q3 2024 buy was Nuvectis Pharma: 55,380 shares worth $348K.
  • Iridian Asset Management added most to LPL Financial in Q3 2024, an estimated $8.16M increase.
  • Iridian Asset Management's biggest Q3 2024 reduction was Crown Holdings, cutting an estimated $6.77M.
  • Iridian Asset Management fully exited Avantor in Q3 2024, selling an estimated $3.44M.
  • Iridian Asset Management's ten largest holdings make up 57% of its $467M portfolio in Q3 2024.
  • Iridian Asset Management opened 4 new positions and closed 2 in Q3 2024.
  • Iridian Asset Management's portfolio value rose 5.4% quarter-over-quarter to $467M.

Based on Iridian Asset Management's 13F filing for Q3 2024, filed 25 Oct 2024.